LK, C., RF, S., C, B., KB, F., Jr, K. J., & JS, S. (2008). Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration. Archives of ophthalmology (Chicago, Ill. : 1960), 126(7), 941. https://doi.org/10.1001/archopht.126.7.941
Chicago Style (17th ed.) CitationLK, Chang, Spaide RF, Brue C, Freund KB, Klancnik JM Jr, and Slakter JS. "Bevacizumab Treatment for Subfoveal Choroidal Neovascularization from Causes Other than Age-related Macular Degeneration." Archives of Ophthalmology (Chicago, Ill. : 1960) 126, no. 7 (2008): 941. https://doi.org/10.1001/archopht.126.7.941.
MLA (9th ed.) CitationLK, Chang, et al. "Bevacizumab Treatment for Subfoveal Choroidal Neovascularization from Causes Other than Age-related Macular Degeneration." Archives of Ophthalmology (Chicago, Ill. : 1960), vol. 126, no. 7, 2008, p. 941, https://doi.org/10.1001/archopht.126.7.941.